Alligator Bioscience Awarded New Patent for its Protein Optimization Technology FIND in Japan
Alligator Bioscience AB announces that the Japan Patent Office has granted the patent application JP 2004-506491 for its protein optimization platform, FIND® (Fragment Induced Diversity). With this patent Alligator Bioscience will have coverage for it's methods in all major markets. The newly-granted patent describes methods of optimization of protein properties and functionalities by in vitro evolution using recombination of single stranded DNA.
"The newly-granted patent in Japan confirms the strength of our expanding portfolio." said Gun-Britt Fransson, chief executive officer of Alligator Bioscience. "The patent covers the core of our company, our proprietary FIND® technology. This platform enables us to build a competitive pipeline of novel and improved versions of biopharmaceuticals. We focus on candidates in inflammation and cancer and our disclosed programs targets the C5a receptor (C5aR), Interleukin 1 (IL-1) and Interleukin 23 (IL-23). We believe this patent will be of crucial importance for our future development on the Japanese market."
Other news from the department research and development
